Nurix Therapeutics, Inc.

NASDAQ:NRIX

Biotechnology

Healthcare
$14.10 +0.85%

+$0.15 today

Market cap
$1.54B
Beta
1.87
P/E (TTM)
-6.4
EPS (TTM)
-$2.68
52W Low $8.20High $22.50

Volume 2.79M

Average 1.74M

Balance Sheet

Inspect the capital base behind the business.

Assets

$688.13M

FY 2025 · Annual

+2.8% YoY

Liabilities

$149.39M

FY 2025 · Annual

+4.9% YoY

Equity

$538.75M

FY 2025 · Annual

+2.2% YoY

Balance Sheet

USD
Metric
FY2021
Nov 2021
FY2022
Nov 2022
FY2023
Nov 2023
FY2024
Nov 2024
FY2025
Nov 2025
Cash & Equivalents80.51M64.47M54.63M110M246.96M
Short-term Investments215.21M244.67M233.28M499.59M345.98M
Net Receivables6.2M1.1M800K1.5M0
Inventory0(1.1M)000
Other Current Assets900K9.31M6.8M8.3M13.88M
Total Current Assets311.12M318.45M295.5M619.39M606.82M
Property, Plant & Equipment (Net)25.35M29.51M47.95M45.9M73.01M
Goodwill00000
Intangible Assets00000
Long-term Investments137.48M63.88M7.42M00
Tax Assets00000
Other Non-current Assets3.12M4.92M4.72M4.06M8.31M
Total Non-current Assets165.65M98.31M60.1M49.96M81.32M
Total Assets476.77M416.76M355.6M669.34M688.14M
Account Payables6.65M5.06M6.4M11.48M11.22M
Short-term Debt3.85M5.53M7.49M00
Tax Payables75K85K30K1.24M0
Deferred Revenue41.21M37.63M48.1M38.36M17.58M
Other Current Liabilities5.67M9.14M751K18.91M23.64M
Total Current Liabilities66.26M70.66M86.96M95.85M86.47M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)59.02M35.97M45.02M26.21M10.01M
Other Non-current Liabilities00000
Total Non-current Liabilities68.21M42.41M68.15M46.5M62.92M
Total Liabilities134.47M113.06M155.11M142.35M149.39M
Common Stock45K47K49K76K102K
Retained Earnings(220.89M)(401.25M)(545.2M)(738.77M)(1B)
Accumulated OCI(608K)(4.32M)(655K)150K105K
Other Stockholders Equity00000
Minority Interest00000
Total Equity342.3M303.7M200.49M526.99M538.75M
Total Debt13.04M11.96M30.61M28.3M55.73M
Net Debt(67.47M)(52.51M)(24.01M)(81.69M)(191.23M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$720.2M
Short-term Investments$328.0M
Receivables$20.0M
Other Current$35.4M
Total Current Assets$1.1B
PP&E (Net)$68.0M
Long-term Investments$14.8M
Other Non-current$8.7M
Total Non-current Assets$91.6M
Total Assets$1.2B

Analysis

Selected assets total $1.2B for Latest. The largest visible component is Cash & Equivalents at $720.2M, about 60.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 5, 2026
4Statement of changes in beneficial ownershipNov 4, 2026
4Statement of changes in beneficial ownershipNov 4, 2026
8-KCurrent reportNov 3, 2026
4Statement of changes in beneficial ownershipNov 2, 2026

How much cash does NRIX have?

Nurix Therapeutics, Inc. (NRIX) reported $246.96M in cash and equivalents in fiscal 2025.

How much debt does NRIX carry?

Nurix Therapeutics, Inc. (NRIX) reported $55.73M of total debt, with net debt of -$191.23M.